대장균에서 증식속도 조절에 의한 수용성 재조합 인간 과립구 콜로니 촉진인자의 생산

Production of Soluble Recombinant Human Granulocyte Colony Stimulating Factor in E. coli by Control of Growth Rate.

  • 박세철 ((주)유한양행 중앙연구소 바이오텍연구실) ;
  • 고인영 (춘천 바이오산업진흥) ;
  • 강희일 ((주)유한양행 중앙연구소 바이오텍연구실)
  • 발행 : 2004.06.01

초록

인간 과립구 성장인자(hG-CSF)는 골수에서 생산되는 단백질로 호중구의 분화 및 생성을 촉진시키는 역할을 한다. 현재 재조합 hG-CSF는 암화학요법에 의한 호중구감소증, 골수이식시 호중구 감소증, 재생불량성 빈혈에 수반되는 호중구 감소증 등으로 적응증이 확대되고 있다. 본 연구에서는 OmpA signal sequence를 삽입하여 인간 과립구 성장인자(hG-CSF)가 분비발현되도록 고안된 T7 promoter 에 의하여 발현되는 pYRCl 발현백터를 제조하였다. E. coli BL2l (pYRCl) 발현시 $37^{\circ}C$에서 배양하는 경우 많은 양의 봉입체(aggregates)를 형성한다. 이에 비하여 $10\mu$M ucose를 포함하는 변형된 MBL배지에서 10 g/$\ell$IPTG를 유도물질로 7시간동안 $25^{\circ}C$에서 배양하였을 때 전체 periplasm단백질의 15%가 soluble rhG-CSF이었다. 또한, 유가식 배양방법을 사용하여 E. coli BL2l(pYRCl)에서 soluble rhG-CSF의 생산조건을 조사하였다. 유가식 배양에서 rhG-CSF의 발현량이 비증식속도를 $0.43 h^{-1}$ 에서 0.14 $h^{-1}$ 으로, 유도 배양시간을 최적화함으로써 rhG-CSF의 발현량이 4.4mg/$\ell$에서 24mg/$\ell$ 로 증가하였다.

Human granulocyte colony-stimulating factor (hG-CSF) is a hematopoiesis agent that principally affects the differentiation of neutrophils in the bone marrow. At present, recombinant hG-CSF is used successfully in the treatment of chemotheraphy-induced neutropenia and its indication has been expanded to bone marrow transplantation and aplastic anemia. In this study, we have constructed rhG-CSF secretion plasmid pYRC1 in which OmpA signal sequence/hG-CSF gene was expressed under the control of the T7 promoter. rhG-CSF produced in E. coli BL21 (pYRC1) grown at $37{\circ}C$ was found in aggregates. However, 15% of the periplasmic protein was soluble rhG-CSF when the E. coli BL21 (pYRC1) was cultured at $25^{\circ}C$ for 7 h in the modified MBL medium containing 10 g/$\ell$ glucose with 10 $\mu$M IPTG induction. The production of soluble rhG-CSF in E. coli BL21 (pYRC1) using fed batch culture was also studied. In the fed batch culture system, the final yield of rhG-CSF produced from E. coli BL21 (pYRC1) was increased from 4.4 mg/$\ell$to 24 mg/$\ell$by controlling the specific growth rate from $0.43 h^{-1}$ to $0.14 h^{-1}$, and optimizing the time of induction.

키워드

참고문헌

  1. Nucleic acid Res. v.14 Secretion of heterologous gene products to the culture medium of E. coli. Abrahmsen, L.;T. Moks;B. Nilsson;M. Uhlen https://doi.org/10.1093/nar/14.18.7487
  2. Science v.236 Human hematopoietic colony-stimulating factor Clark, S. C.;R. Kamen https://doi.org/10.1126/science.3296190
  3. Appl. Environ. Microbiol. v.62 Overproduction of recombinant ribulose 1,5-biphosphate carboxylase/oxygenase from Synechococcus sp. strain PCC 6301 in glucose-controlled high cell-density fermentations by Escherichia coli K-12 Gary, L. K.;M. Horken;F. R. Tabita;W. R. Strohl
  4. J. Biol. Chem. v.262 An increase content of protease La, the Lon gene product, increases protein degradation and block growth in E. coli. Goff, S. A.;A. L. Goldberg
  5. Bio/Technol. v.6 Control of folding of proteins secreted a high expression serection vector, PIN--ompA: 16-fold increase in production of active subtilisin E in E. coli. Hiroshi, T.;Y. Morinaga;M. Tsuchiya;H. Ikemura;M. Inouye https://doi.org/10.1038/nbt0888-948
  6. Biotechnol. lett. v.17 High level expression and simple purification of recombinant human granulocyte colony-stimulating factor in E. coli. Kang, S. H.;K .H .Na;J. H. Park;C. I. Park;S. Y. Lee;Y. I. Lee https://doi.org/10.1007/BF00130351
  7. J. Biol. Chem. v.266 Modified enterotoxin signal sequences increase secretion level of the rhEGF in E. coli. Kazuko, M. F.;R. Marumoto;T. Fukuda
  8. Biotechnol. Lett. v.10 Production of human leukocyte interferon on E. coli by control of growth rate in fed-batch fermentation Lee, J. H.;Y. H. Choi;S. K. Kang;H. H. Park;I. B. Kwon
  9. J. Biol. Chem. v.267 Effects of overproduction of heat shock chaperones GroESL and Dnak procollagenase production in Escherichia coli Lee, S. C.;P. O. Olins
  10. Bioassay v.10 Gene structure and function of granulocyte colony-stimulating factor Nagata, S.
  11. Nature v.319 Molecular cloning and expression of cDNA for human granulocyte colony stimulating factor Nagata, S.;M. Tsuchiya;S. Asano;Y. Kaziro;T. Yamazaki;O. Yamamoto;Y .Hirata;N. Kubota;M. Oheda;H. Nomura;M. Ono https://doi.org/10.1038/319415a0
  12. Methods Enzymol. v.116 Granulocyte colony stimulating factor Nicola, N. A. https://doi.org/10.1016/S0076-6879(85)16046-5
  13. PET system manual(4th ed.) Novagen Inc.
  14. Curr. Opinion Biotechnol. v.2 High cell density cultivation of E. coli. Riesenberg, D. https://doi.org/10.1016/S0958-1669(05)80142-9
  15. Science v.238 The molecular control of blood cell development Sachs, L. https://doi.org/10.1126/science.3317831
  16. Molecular Cloning(3rd ed.) Sambrook, J.;D. W. Russel
  17. Biotechnol. v.3 Isolation and purification of protein granules from Escherichia coli cells overproducing bovine growth hormone Schoner, R. G.;L. F. Ellis;B. E. Schoner https://doi.org/10.1038/nbt0285-151
  18. Laboratory of Biological Chemistry (2nd ed.) Dinitrosalicylic method for glucose Sumner, J. V.;G. F. Somers
  19. Proc. Natl. Acad. Sci. USA v.82 Synthesis and secretion of human epidermal growth factor by Escherichia coli Takanori, O.;S. Sakamoto;K. Miyoshi;T. Fuwa;K. Yoda;M. Yamasaki;G. Tamura;T. Miyake https://doi.org/10.1073/pnas.82.21.7212
  20. Proc. Natl. Acad. Sci. v.76 Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets : procedure and some applications Towbin, H. T.;T. Staehelin;J. Gordon https://doi.org/10.1073/pnas.76.9.4350
  21. Biotechnol. Lett. v.10 Production of human epidermal growth factor by an ampicillin resistant recombinant E. coli strain. Yadwad, V. B.;S. Wilson;O. P. Ward https://doi.org/10.1007/BF01025284